AUTHOR=Belaya Zhanna , Khandaeva Patimat , Nonn Larisa , Nikitin Alexey , Solodovnikov Alexander , Sitkin Ivan , Grigoriev Andrey , Pikunov Mikhail , Lapshina Anastasia , Rozhinskaya Liudmila , Melnichenko Galina , Dedov Ivan 

TITLE=Circulating Plasma microRNA to Differentiate Cushing's Disease From Ectopic ACTH Syndrome

JOURNAL=Frontiers in Endocrinology

VOLUME=11

YEAR=2020

URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2020.00331

DOI=10.3389/fendo.2020.00331

ISSN=1664-2392

ABSTRACT=<p>Corticotropinomas and adrenocorticotropic hormone (ACTH)-secreting neuroendocrine tumors exhibit differential levels of some microRNAs (miRs) compared to normal tissue. Because miRs can be released from tissues into circulation, they offer promise as novel disease biomarkers.</p><p><bold>Objective:</bold> To evaluate whether miRs are differentially detected in plasma samples of patients with ACTH-dependent Cushing's syndrome (CS).</p><p><bold>Design:</bold> Case-control study.</p><p><bold>Methods:</bold> Morning fasting plasma samples were collected from 41 consecutive patients with confirmed ACTH-dependent CS and 11 healthy subjects and stored at −80°C. Twenty-one miRs previously reported to be differentially expressed in ACTH-secreting tumors vs. healthy tissue samples were quantified in plasma by qPCR.</p><p><bold>Results:</bold> Among enrolled subjects, 28 were confirmed to have Cushing's disease (CD), 13 had ectopic ACTH secretion (EAS) and 11 were healthy controls. We found statistically significant differences in the circulating levels of miR-16-5p [45.04 (95% CI 28.77–61.31) in CD vs. 5.26 (2.65–7.87) in EAS, <italic>P</italic> &lt; 0.001; <italic>q</italic> = 0.001], miR-145-5p [0.097 (0.027–0.167) in CD vs. undetectable levels in EAS, <italic>P</italic> = 0.008; <italic>q</italic> = 0.087] and differences in miR-7g-5p [1.842 (1.283–2.400) in CD vs. 0.847 (0.187–1.507) in EAS, <italic>P</italic> = 0.02; <italic>q</italic> = 0.14]. The area under the receiver-operator (ROC) curve was 0.879 (95% CI 0.770–0.987), <italic>p</italic> &lt; 0.001, when using miR-16-5p to distinguish between CD and EAS. Circulating levels of miR-16-5p in the healthy control group differed from that of both the CD and EAS groups.</p><p><bold>Conclusions:</bold> Plasma miR levels differ in patients with CD and EAS. In particular, miR-16-5p, miR-145-5p and miR-7g-5p are promising biomarkers for further research to differentiate ACTH-dependent CS.</p>